The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Vereshchagina G.N.

GOU VPO NGMU Minzdrava RF

Irkhina I.S.

GOU VPO NGMU Minzdrava Rossii

Ermakova É.N.

GOU VPO NGMU Minzdrava RF

Poltaranina G.G.

OBUZ Gorodskaia klinicheskaia bol'nitsa #25, Novosibirsk

Novikova O.N.

Obstetrics and Gynecology Department One, Kemerovo State Medical Academy, Ministry of Health of Russia, Kemerovo, Russia

Mexidol in scheme of combined therapy of chronic heart failure of the 2nd-3nd functional classes

Authors:

Vereshchagina G.N., Irkhina I.S., Ermakova É.N., Poltaranina G.G., Novikova O.N.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2013;6(6): 60‑63

Read: 18414 times

Download PDF (RU)
Contact the author
Table of contents

MEXIDOL IN SCHEME OF COMBINED THERAPY OF CHRONIC HEART FAILURE OF THE 2ND-3ND FUNCTIONAL CLASSES
MEXIDOL IN SCHEME OF COMBINED THERAPY OF CHRONIC HEART FAILURE OF THE 2ND-3ND FUNCTIONAL CLASSES

To cite this article:

Vereshchagina GN, Irkhina IS, Ermakova ÉN, Poltaranina GG, Novikova ON. Mexidol in scheme of combined therapy of chronic heart failure of the 2nd-3nd functional classes. Russian Journal of Cardiology and Cardiovascular Surgery. 2013;6(6):60‑63. (In Russ.)

Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Risk factors and adve­rse outcomes of cardiovascular diseases in people with high normal blood pressure of the Ryazan region. (5-year prospective follow-up). Russian Journal of Preventive Medi­cine. 2025;(2):31-37
Characteristics of the myocardial stru­ctural and functional para­meters depe­nding on the meta­bolic phenotype of the Arkhangelsk city resi­dents. Russian Journal of Preventive Medi­cine. 2025;(2):53-60
Dyna­mics of arte­rial stiffness indi­cators during anti­hypertensive therapy. Russian Journal of Preventive Medi­cine. 2025;(2):74-79
The effect of Mexi­dol on the level of neurogenesis markers in acute cere­brovascular acci­dent in the expe­riment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):107-112
Prevalence of cere­brovascular diseases risk factors acco­rding to the cohort survey data in Bishkek, Kyrgyz Repu­blic. Russian Journal of Preventive Medi­cine. 2025;(3):34-39
The effect of the iron III poly­saccharide complex use on the cyto­kines, natriuretic peptide and erythropoietin levels in patients with chro­nic heart failure acco­mpanied with anemia. Russian Journal of Preventive Medi­cine. 2025;(3):80-86
Asso­ciations between the gut microbiota-derived meta­bolites with the para­meters of 24-hour ambu­latory blood pressure moni­toring in patients on maintenance hemo­dialysis. Russian Journal of Preventive Medi­cine. 2025;(3):96-102
Personal characteristics of patients with cere­bral microangiopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):51-56
Prognostic significance of NT-proBNP and sST2 in patients with chro­nic heart failure and redu­ced ejection fraction after previous deco­mpensation. Russian Cardiology Bulletin. 2025;(1):49-56
Dyna­mics of vector electrocardiography para­meters in patients with chro­nic heart failure under opti­mal drug therapy. Russian Cardiology Bulletin. 2025;(1):57-63
Abstract:

Keywords:

chronic heart failure
mexidol
arterial hypertension

Authors:

Vereshchagina G.N.

GOU VPO NGMU Minzdrava RF

Irkhina I.S.

GOU VPO NGMU Minzdrava Rossii

Ermakova É.N.

GOU VPO NGMU Minzdrava RF

Poltaranina G.G.

OBUZ Gorodskaia klinicheskaia bol'nitsa #25, Novosibirsk

Novikova O.N.

Obstetrics and Gynecology Department One, Kemerovo State Medical Academy, Ministry of Health of Russia, Kemerovo, Russia

Close metadata

References:

  1. Andreeva N.N. Eksperimental'nye i klinicheskie aspekty primeneniya meksidola pri gipoksii. Med al'manakh 2009; 4: 193-197.
  2. Atroshchenko E.S. Patsient s khronicheskoi serdechnoi nedostatochnost'yu i sokhranennoi sistolicheskoi funktsiei levogo zheludochka. Serdechnaya nedostatochnost' 2007; 6: 297-300.
  3. Atroshchenko E.S. Puti optimizatsii lecheniya serdechnoi nedostatochnosti. Serdechnaya nedostatochnost' 2002; 4: 27-30.
  4. Belaya O.L., Baider L.M., Kuropteva Z.V., Fomina I.G. Vliyanie meksidola na antioksidantnyi status u bol'nykh ishemicheskoi bolezn'yu serdtsa. Klin med 2005; 10: 57-60.
  5. Gorokhova S.G. Osobennosti khronicheskoi serdechnoi nedostatochnosti v pozhilom i starcheskom vozraste. Klin gerontol 2002; 2: 44-52.
  6. Gurevich M.A. Nekotorye osobennosti kliniki i lecheniya khronicheskoi serdechnoi nedostatochnosti u pozhilykh. Ros kardiol zhurn 2002; 1: 81-84.
  7. Izbrannye lektsii po kardiologii. Pod red. E.V. Shlyakhto SPb: LadogaB 2006.
  8. Metelitsa V.I. Spravochnik po klinicheskoi farmakologii serdechno-sosudistykh sredstv. M: MIA 2005.
  9. Natsional'nye rekomendatsii VNOK i OSSN po diagnostike i lecheniyu KhSN (tretii peresmotr). Komitet po podgotovke teksta: Mareev V.Yu., Ageev F.T., Arutyunov G.P. i dr. Serdechnaya nedostatochnost' 2009; 2: 64-103.
  10. Okovityi S.V., Smirnov A.V. Antigipoksanty. Eksper i klin farmakol 2001; 64: 76-80.
  11. Ol'binskaya L.I., Sizova Zh.M. Farmakoterapiya khronicheskoi serdechnoi nedostatochnosti. Rus vrach 2002; 2: 6-7.
  12. Preobrazhenskii D.V., Sidorenko B.A., Vyshinskaya I.D. Khronicheskaya serdechnaya nedostatochnost' u lits pozhilogo i starcheskogo vozrasta: osobennosti patofiziologii i medikamentoznogo lecheniya. Klin gerontol 2007; 6: 33-43.
  13. Provotorov V.M., Burlova E.S. Diagnostika khronicheskoi serdechnoi nedostatochnosti na rannikh stadiyakh u lits pozhilogo vozrasta. Klin gerontol 2007; 6: 57-62.
  14. Preobrazhenskii D.V., Sidorenko B.A., Vyshinskaya I.D. Khronicheskaya serdechnaya nedostatochnost' u lits pozhilogo i starcheskogo vozrasta: osobennosti patofiziologii i medikamentoznogo lecheniya. Klin gerontol 2007; 6: 33-44.
  15. Bristow M. Why does the myocardium fail? Insights from basic science. Lancet 1998; 3: 11: 203-214.
  16. Cleland J.G., Swedberg K., Follath F. et al. The EuroHeart Failure survey programme a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003; 5: 24: 442-463.
  17. Guidelines for the diagnosis and treatment of Chronic Heart Failure: full text (update 2005) The task force for the diagnosis and treatment of CHF of the European Society of Cardiology. Eur Heart J 2005; 26: 22: 2472.
  18. Hunter J., Chien K., Grace A. Molecular and cellular biology of cardiac hypertrophy and failure. In: Molecular basis of cardiovascular disease. Eds. R. Kenneth, W.B. Chien. Philadelphia: Saunders 1999.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.